Dosidal · Switzerland
Kymriah, Zellsuspension zur Infusion
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:66778 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 66778 atc: L01XL04 |
| Source authority | Swissmedic |
| Read date | 2026-11-15T01:25:13Z |
| authorisation status | first_authorisation: 2018-10-18 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: L01XL04 authorisation_number: 66778 form: INFD holder: Novartis Pharma Schweiz AG holder_partner_nr: 1006575 it_number: 07.16.4. name: Kymriah, Zellsuspension zur Infusion state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53pNj9PWWfuZb9TOPIlYbBtsXtNhCK4oIxNziPRAR70NJ1Mcd-sRdMQcjd47sSE0aaFZKtpTcajB1g6VqQcUh_tgThe signed record is on this page as issued. Keyring and how to check it: https://dosidal-registry.ai/.well-known/jwks.json |
The signed record (DOSE-10060, JSON)
{"as_of":null,"authority":{"id":"66778","name":"Swissmedic","register":"OGD Praeparate"},"fields":{"authorisation_status":{"asserted_by":"node","clock":{"class":"short","expires_at":"2026-11-22T01:25:13Z"},"effective_from":"2018-10-18","read_at":"2026-11-15T01:25:13Z","source":{"published":"2026-10-31","publisher":"Swissmedic (OGD)","url":"https://ogd.swissmedic.cloud/ogd-arzneimittel/Daten/OGD.zip"},"state":"current","value":{"first_authorisation":"2018-10-18","term":"zugelassen","valid_until":"9999-12-31"}},"identity":{"asserted_by":"node","clock":{"class":"long","expires_at":"2027-02-13T01:25:13Z"},"effective_from":"2018-10-18","read_at":"2026-11-15T01:25:13Z","source":{"published":"2026-10-31","publisher":"Swissmedic (OGD)","url":"https://ogd.swissmedic.cloud/ogd-arzneimittel/Daten/OGD.zip"},"state":"current","value":{"atc":"L01XL04","authorisation_number":"66778","form":"INFD","holder":"Novartis Pharma Schweiz AG","holder_partner_nr":"1006575","it_number":"07.16.4.","name":"Kymriah, Zellsuspension zur Infusion"}}},"instance":"CH-DOSE-10060","instance_version":"0.1","market":"CH","node":{"door":"https://mcp.dosidal.ai","id":"ch.dose-10060.org"},"notice":"Artificial intelligence makes mistakes. Read the regulator.","produced_at":"2026-11-15T01:25:15Z","record_id":"ch:authorisation:66778","schema_version":"1.0","signature":{"alg":"ES256","canon":"JCS","kid":"dosidal-record-1.9dbf5d53","sig":"pNj9PWWfuZb9TOPIlYbBtsXtNhCK4oIxNziPRAR70NJ1Mcd-sRdMQcjd47sSE0aaFZKtpTcajB1g6VqQcUh_tg"},"standard":"DOSE-10060","standard_version":"1.0","subject":{"anchor":null,"id":"ch:authorisation:66778","identifiers":[{"system":"swissmedic-authorisation","value":"66778"},{"system":"atc","value":"L01XL04"}],"level":"authorisation","relations":[{"id":"ch:presentation:66778-001","rel":"authorisation_of"}]},"supersedes":null,"version":1}